Key terms
About CYCN
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CYCN news
No recent news articles are available for CYCN
No recent press releases are available for CYCN
CYCN Financials
Key terms
Ad Feedback
CYCN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CYCN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range